Literature DB >> 17405826

Ghrelin and its unacylated isoform stimulate the growth of adrenocortical tumor cells via an anti-apoptotic pathway.

P J D Delhanty1, P M van Koetsveld, C Gauna, B van de Zande, G Vitale, L J Hofland, A J van der Lely.   

Abstract

Ghrelin is expressed in normal human adrenocortical cells and induces their proliferation through growth hormone secretagogue receptor 1a (GHS-R1a). Consequently, it was of interest to us to determine whether acylated ghrelin and its predominant serum isoform, unacylated ghrelin, also act as factors for adrenocortical carcinoma cell growth. To examine a potential ghrelin-regulated system in adrenocortical tumors, we measured proliferative effects of acylated and unacylated ghrelin in the adrenocortical carcinoma cell lines SW-13 and NCI-H295R. We also examined the expression of ghrelin, GHS-R1a, and corticotrophin-releasing factor receptor 2 (CRF-R2). Acylated and unacylated ghrelin in the nanomolar range dose-dependently induced adrenocortical cell growth up to 200% of untreated controls, as measured by thymidine uptake and WST1 assay. The proliferative effects of acylated and unacylated ghrelin in SW-13 cells was blocked by [D-Lys(3)]growth hormone-releasing peptide 6 (GHRP6), but a CRF-R2 antagonist had no effect on unacylated ghrelin growth stimulation. Cell cycle analysis suggests that acylated and unacylated ghrelin suppress the sub-G(0)/apoptotic fraction by up to 50%. Measurement of DNA fragmentation and caspase-3 and -7 activity in SW-13 cells confirmed that acylated and unacylated ghrelin suppress apoptotic rate. SW-13 cells express preproghrelin mRNA and secrete ghrelin, and [D-Lys(3)]GHRP6 suppresses their basal proliferation rate, strongly suggesting that ghrelin could act as an auto/paracrine growth factor. Acylated and unacylated ghrelin are potential auto/paracrine factors acting through an antiapoptotic pathway to stimulate adrenocortical tumor cell growth. Unacylated ghrelin-stimulated growth is suppressed by an antagonist of GHS-R1a, suggesting either that unacylated ghrelin is acylated before its action or that ghrelin, unacylated ghrelin, and [D-Lys(3)]GHRP-6 bind to a novel receptor in these cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17405826     DOI: 10.1152/ajpendo.00377.2006

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  16 in total

Review 1.  Ghrelin O Acyl Transferase (GOAT) as a Novel Metabolic Regulatory Enzyme.

Authors:  Mahalaqua Nazli Khatib; Shilpa Gaidhane; Abhay M Gaidhane; Padam Simkhada; Quazi Syed Zahiruddin
Journal:  J Clin Diagn Res       Date:  2015-02-01

2.  Expression and in vitro functions of the ghrelin axis in endometrial cancer.

Authors:  Jenny N T Fung; Inge Seim; Dengfeng Wang; Andreas Obermair; Lisa K Chopin; Chen Chen
Journal:  Horm Cancer       Date:  2010-10       Impact factor: 3.869

3.  pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma: a tissue-microarray study with clinic-pathological correlations.

Authors:  Gabriella Aquino; Giuseppe Pannone; Angela Santoro; Giuseppina Liguori; Renato Franco; Rosario Serpico; Gianluca Florio; Alfredo De Rosa; Marilena Mattoni; Valentina Cozza; Gerardo Botti; Simona Losito; Francesco Longo; Stefania Staibano; Giovanni Cuda; Lorenzo Lo Muzio; Carolina Sbordone; Pantaleo Bufo; Anna Grimaldi; Michele Caraglia; Marina Di Domenico
Journal:  Cancer Biol Ther       Date:  2012-07-24       Impact factor: 4.742

4.  Hypotensive effects of ghrelin receptor agonists mediated through a novel receptor.

Authors:  Brid Callaghan; Samin Kosari; Ruslan V Pustovit; Daniela M Sartor; Dorota Ferens; Kung Ban; Jonathan Baell; Trung V Nguyen; Leni R Rivera; James A Brock; John B Furness
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

5.  Ghrelin increases lymphocytes in chronic normobaric hypoxia.

Authors:  Fariba Mirzaie Bavil; Gisou Mohaddes; Hadi Ebrahimi; Rana Keyhanmanesh; Rafigheh Ghiyasi; Mohammad Reza Alipour
Journal:  Adv Pharm Bull       Date:  2014-08-10

Review 6.  Current and potential roles of ghrelin in clinical practice.

Authors:  G Angelidis; V Valotassiou; P Georgoulias
Journal:  J Endocrinol Invest       Date:  2010-12       Impact factor: 4.256

7.  Integrating GHS into the Ghrelin System.

Authors:  Johannes D Veldhuis; Cyril Y Bowers
Journal:  Int J Pept       Date:  2010-03-18

8.  Acylated ghrelin protects hippocampal neurons in pilocarpine-induced seizures of immature rats by inhibiting cell apoptosis.

Authors:  Ruiyun Zhang; Guanglu Yang; Qingyi Wang; Feng Guo; Hua Wang
Journal:  Mol Biol Rep       Date:  2012-11-06       Impact factor: 2.316

Review 9.  Actions and therapeutic pathways of ghrelin for gastrointestinal disorders.

Authors:  Michael Camilleri; Athanasios Papathanasopoulos; Suwebatu T Odunsi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-06       Impact factor: 46.802

10.  The ghrelin O-acyltransferase-ghrelin system reduces TNF-α-induced apoptosis and autophagy in human visceral adipocytes.

Authors:  A Rodríguez; J Gómez-Ambrosi; V Catalán; F Rotellar; V Valentí; C Silva; C Mugueta; M R Pulido; R Vázquez; J Salvador; M M Malagón; I Colina; G Frühbeck
Journal:  Diabetologia       Date:  2012-08-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.